Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 5mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 10mg		Capsule, hard	1,358,625 L.L
M05BA07	RISEDRONATE ARROW	G	Risedronate sodium - 35mg	35mg	Tablet, film coated	671,921 L.L
N02CC04	RIZATRIPTAN ARROW	G	Rizatriptan - 10mg	10mg	Tablet	1,182,581 L.L
C03BA11	RAWEL SR	G	Indapamide - 1.5mg	1.5mg	Tablet, prolonged release	362,837 L.L
M01AB05	REMETHAN	G	Diclofenac sodium - 50mg	50mg	Tablet	196,201 L.L
A02BC01	RISEK	G	Omeprazole - 20mg	20mg	Capsule, enteric coated	302,365 L.L
M01AB05	ROFENAC D	G	Diclofenac free acid - 50mg	50mg	Tablet, dispersible	408,528 L.L
A02BC01	RISEK	G	Omeprazole - 40mg	40mg	Capsule, enteric coated	522,755 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 2mg	2mg	Tablet	831,839 L.L
R05DB13	RAPICOD	G	Butamirate citrate - 0.15%	0.15%	Syrup	296,989 L.L
A02BC01	RISEK	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	592,635 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 0.5mg	0.5mg	Tablet	831,839 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 1.5mg	1.5mg	Capsule, hard	6,394,003 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 3mg	3mg	Capsule, hard	6,394,003 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 1mg	1mg	Tablet	831,839 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 4.5mg	4.5mg	Capsule, hard	6,394,003 L.L
N05AX15	REAGILA	G	Cariprazine - 6mg	6mg	Capsule, hard	6,394,003 L.L
G04BE08	RAVANA	G	Tadalafil - 20mg	20mg	Tablet	500,421 L.L
N01AH06	REMIFENTANIL MEDIS	G	Remifentanil (HCl) - 1mg	1mg	Injectable powder	1,101,951 L.L
N01AH06	REMIFENTANIL MEDIS	G	Remifentanil (HCl) - 5mg	5mg	Injectable powder	2,576,146 L.L
P01AB01	RAMAZOL	G	Metronidazole - 500mg	500mg	Tablet	216,359 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	727,019 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
D10AD01	RETACNYL - 0.05 %	G	Tretinoin - 0.05%		Cream	584,571 L.L
V03AB35	RELANCIUM	G	Sugammadex - 100mg/ml	100mg/ml	Injectable solution	45,660,028 L.L
M01AB05	RAPIDUS	G	Diclofenac potassium - 50mg	50mg	Tablet, coated	287,582 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
C10AA07	ROSUCOR	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	487,623 L.L